IRVINE, Calif.--(BUSINESS WIRE)--Cortex Pharmaceuticals, Inc. (AMEX: COR), a neuroscience company focused on developing novel AMPAKINE® drug therapies for neurological and psychiatric disorders, will web cast presentations from its annual shareholder meeting scheduled for Wednesday, May 9, 2007, at 10:30 a.m., Pacific Daylight Time, at the Fairmont Newport Beach Hotel, 4500 MacArthur Boulevard, in Newport Beach, California. In the informal part of the meeting, Cortex will update shareholders on the latest information related to the development of high impact AMPAKINE drugs in transgenic animal models for treatment of Orphan diseases such as Huntington’s Disease, Fragile X, and Rett’s syndrome, and progress with the low impact program and specifically update shareholders regarding the latest submission to the FDA for CX717.
